102 related articles for article (PubMed ID: 3465128)
21. [The immunological assessment of a combined therapeutic approach (chemo- + radiotherapy +/- surgery) including immunotherapy in neoplasms of the head and neck area at an advanced stage].
Mantovani G; Ghiani M; Bianchi A; Curreli L; Contini L; Macciò A; Santona MC; Proto E; Cossu F; Puxeddu P
Recenti Prog Med; 1995 Jan; 86(1):8-16. PubMed ID: 7709042
[TBL] [Abstract][Full Text] [Related]
22. Decreased sensitivity of T lymphocytes to normal adherent suppressor cells in patients with head and neck cancer.
Pierri I; Cordone G; Rogna S; Pende D; Garaventa G; Barabino A; Indiveri F
Cancer Detect Prev; 1984; 7(2):73-8. PubMed ID: 6231991
[TBL] [Abstract][Full Text] [Related]
23. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2.
Meneses A; Verastegui E; Barrera JL; de la Garza J; Hadden JW
Int Immunopharmacol; 2003 Aug; 3(8):1083-91. PubMed ID: 12860165
[TBL] [Abstract][Full Text] [Related]
24. Chemo-immunotherapy in advanced head and neck cancer.
Recchia F; Sica G; De Filippis S; Rosselli M; Pompili P; Saggio G; Rea S
Anticancer Res; 1999; 19(1B):773-7. PubMed ID: 10216492
[TBL] [Abstract][Full Text] [Related]
25. [Interleukin 2 and local immunotherapy of head and neck cancer].
Wu H; Tu GY
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1991; 26(6):367-9. PubMed ID: 1811693
[No Abstract] [Full Text] [Related]
26. [The observation on treatment effects of local adoptive immunotherapy in 33 cases with head and neck cancer].
Han D; Zhu X; Huang Z
Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):454-6. PubMed ID: 10920882
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer.
Uchida T; Horiguchi S; Tanaka Y; Yamamoto H; Kunii N; Motohashi S; Taniguchi M; Nakayama T; Okamoto Y
Cancer Immunol Immunother; 2008 Mar; 57(3):337-45. PubMed ID: 17690880
[TBL] [Abstract][Full Text] [Related]
28. [Immunotherapy and its possible application in malignomas of the orofacial region. Review].
Stanko P
Prakt Zubn Lek; 1989 Aug; 37(8):236-8. PubMed ID: 2701242
[TBL] [Abstract][Full Text] [Related]
29. [Therapy of patients with head and neck neoplasms using cytotoxic T lymphocytes].
IshikawaT ; Eura M; Chikamatsu K; Fukie T; Murakami K; Matsuoka H; Nakano K; Sameshima Y; Masuyama K; Inokawa T
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):621-4. PubMed ID: 8963765
[No Abstract] [Full Text] [Related]
30. Stage IV head and neck cancer: a follow-up.
Ryan RF; Truesdale GL
J La State Med Soc; 1982 Oct; 134(7):35-8. PubMed ID: 7175332
[No Abstract] [Full Text] [Related]
31. Immunologic aspects of head and neck cancer.
Dichtel WJ
Ear Nose Throat J; 1981 Oct; 60(10):97-100, 102,-6. PubMed ID: 7308093
[No Abstract] [Full Text] [Related]
32. [Progress in head and neck cancer].
Ballivet de Régloix S; Dubray-Vautrin A; Girod A; Jouffroy T; Rodriguez J
Soins; 2015 Sep; (798):56; quiz 57. PubMed ID: 26369749
[No Abstract] [Full Text] [Related]
33. Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck.
Mayer A; Andratschke M; Pauli C; Graefe H; Kristina K; Wollenberg B
Anticancer Res; 2005; 25(6B):4075-80. PubMed ID: 16309201
[TBL] [Abstract][Full Text] [Related]
34. Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck.
Hoffmann TK; Bier H; Whiteside TL
Cancer Immunol Immunother; 2004 Dec; 53(12):1055-67. PubMed ID: 15095020
[TBL] [Abstract][Full Text] [Related]
35. Current role of gene therapy in head and neck cancer.
Ganly I; Soutar DS; Kaye SB
Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
[TBL] [Abstract][Full Text] [Related]
36. [Current status and future perspective for immunotherapy in head and neck cancer patients].
Okamoto Y
Nihon Jibiinkoka Gakkai Kaiho; 2013 Feb; 116(2):118-9. PubMed ID: 24163852
[No Abstract] [Full Text] [Related]
37. Head and neck cancer antigens recognized by the humoral immune system.
Monji M; Senju S; Nakatsura T; Yamada K; Sawatsubashi M; Inokuchi A; Nishimura Y
Biochem Biophys Res Commun; 2002 Jun; 294(3):734-41. PubMed ID: 12056832
[TBL] [Abstract][Full Text] [Related]
38. Alcohol consumption and cellular immunocompetence.
Palmer DL
Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):13-7. PubMed ID: 619200
[No Abstract] [Full Text] [Related]
39. Recent advances in immunology with specific reference to otolaryngology.
Naclerio R
Otolaryngol Clin North Am; 1985 Nov; 18(4):821-32. PubMed ID: 3909062
[TBL] [Abstract][Full Text] [Related]
40. Clinical trials referral resource. Clinical trials in head and neck cancer.
Conley BA; Cheson BD
Oncology (Williston Park); 1997 Oct; 11(10):1527-30. PubMed ID: 9348557
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
